DrugDashboards
← Home
Manufacturing facility

Mpp Pharma Llc

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
United States
Registered address
1800 N Topping Avenue, Kansas City, Missouri (MO) 64120, United States (USA)
Operations here
analysislabelmanufacturepack
FDA identifiers
FEI 1930436 · DUNS 137555154

Recent inspection flagged official action

FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 7 drugs. A supply problem here can ripple to all of them.

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • OAIDrug Quality Assurance2026-04-02
  • VAIBioresearch Monitoring2024-09-20
  • VAIDrug Quality Assurance2024-09-13
  • VAIDrug Quality Assurance2021-04-21
  • NAIBioresearch Monitoring2016-04-04
  • VAIDrug Quality Assurance2016-04-04
  • VAIDrug Quality Assurance2014-02-19
  • VAIDrug Quality Assurance2013-01-30
  • VAIDrug Quality Assurance2010-11-05
  • OAIBioresearch Monitoring2009-12-01
  • OAIDrug Quality Assurance2009-12-01
  • OAIDrug Quality Assurance2008-11-14

Drugs this plant is listed as making

7 distinct drugs across 12 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.